delivery system
Othersyringe
NCT Number: NCT01008605
The purpose of this study is to demonstrate the usability of the system.
Looking for future studies?
Notify Me40 year–70 year
Male
Interventional
Phase 3
Pfizer Investigational Site, Overland Park, Kansas, United States
demonstrate usability
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Age 40 to 70
Exclusion criteria
Prior syringe skills
syringe
Time frame: Day 1
Percentage of participants who were able to successfully expel the selected dose from the Caverject Impulse Delivery System when relying on the modified Instructions for Use. The process was considered successful if the lower bound of the 95% confidence interval (CI) was more than (>) 80% overall.
Time frame: Day 1
Participant Assessment Tool, Question 1: Instructions provided were useful? Participant responses were reported as follows: Very Useful, Somewhat Useful, Not Very Useful, Not Useful At All.
Time frame: Day 1
Participant Assessment Tool, Question 2: Instructions provided were clear? Participant responses were reported as follows: Very Clear, Somewhat Clear, Not Very Clear, Not Clear At All.
Time frame: Day 1
Participant Assessment Tool, Question 3: Most difficult step? Participant responses were reported as follows: No Steps Particularly Difficult, Attaching Needle, Mixing Solution, Getting The Air Out Of Syringe, Dialing Dose, Pushing Plunger, Other.
Time frame: Day 1
Participant Assessment Tool, Question 4: Syringe easy to use? Participant responses were reported as follows: Very Easy, Somewhat Easy, Somewhat Difficult, Very Difficult
Time frame: Day 1
Steps involved while using the Caverject Impulse Delivery System included assembly, mixing the dose, de-aeration, setting the dose, and injecting the dose.
Time frame: Day 1
Number of participants providing comments on questions in the Participant Assessment Tool. Questions were as follows: were instructions clear, were instructions useful, which was the most difficult step, and was the syringe easy to use.
Pfizer
Industry
Representative Users Study Of Operating Characteristics Of The Caverject Delivery System.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07715448
Benign Prostatic Hyperplasia, Ejaculatory Dysfunction
Banī Suwayf, Beni Suef Governorate, Egypt
View Trial DetailsNCT06805513
Erectile Dysfunction, Genital Diseases
Salt Lake City, Utah, United States
View Trial DetailsNCT07692867
Erectile Dysfunction, Genital Diseases
Beijing, China
View Trial DetailsNCT07460167
Erectile Dysfunction, Genital Diseases
Qina, Egypt
View Trial Details